3.0.0 5815 2023-01-11T13:25:13Z 2023-01-11T13:25:13Z House H HR 2014-12-09 113 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. COLLINS of Georgia:H.R. 5815.Congress has the power to enact this legislation pursuantto the following:The Constitutional authority in which this bill rests isthe power of Congress to regulate Commerce as enumerated inArticle I, Section 8, Clause 3, as applied to healthcare.[Page H8931]]]> hsif00 Energy and Commerce Committee House Standing hsif03 Energy, Climate and Grid Security Subcommittee Referred to 2014-12-12T20:38:06Z Referred to 2014-12-09T15:01:35Z hsgo00 Oversight and Accountability Committee House Standing Referred to 2014-12-09T15:01:50Z hsas00 Armed Services Committee House Standing Referred to 2014-12-09T15:01:45Z hswm00 Ways and Means Committee House Standing Referred to 2014-12-09T15:01:40Z Generic Drug Pricing Fairness Act 113 4437 HR 2014-04-11 Referred to the Subcommittee on Health. Related bill CRS 2014-12-12 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Referred to the Subcommittee on Energy and Power. Committee 2014-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsgo00 Oversight and Accountability Committee 2014-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsas00 Armed Services Committee 2014-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2014-12-09 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2014-12-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2014-12-09 Introduced in House IntroReferral 1000 9 Library of Congress C001093 Rep. Collins, Doug [R-GA-9] Doug Collins R GA 9 N L000565 Rep. Loebsack, David [D-IA-2] David Loebsack D IA 2 2014-12-09 True Health Administrative remedies Consumer affairs Contracts and agency Government employee pay, benefits, personnel management Health care costs and insurance Health information and medical records Insurance industry and regulation Medical ethics Medicare Military medicine Prescription drugs Public contracts and procurement Retail and wholesale trades Right of privacy Health 00 2014-12-09 Introduced in House 2014-12-16T20:16:40Z Generic Drug Pricing Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each contract entered into with a prescription drug plan (PDP) sponsor with respect to a PDP the sponsor offers to prohibit the PDP from entering into a contract with any pharmacy benefits manager (PBM) to manage the prescription drug coverage provided under such plan, or to control the costs of the prescription drug coverage under it, unless the PBM adheres to specified criteria when handling personally identifiable utilization and claims data or other sensitive patient data.

Revises requirements for contracts with PDP sponsors to require that the PDP sponsor disclose to applicable pharmacies the sources used for making any update of the prescription drug pricing standard, and if the source for such a standard is not publicly available, disclose to such pharmacies all individual drug prices to be so updated in advance of their use for the reimbursement of claims.

Requires the PDP sponsor, as well, to establish a process to appeal, investigate, and resolve disputes regarding individual drug prices that are less than the pharmacy acquisition price for a drug.

Directs the Secretary of Defense (DOD), with respect to the TRICARE retail pharmacy program, to ensure that a contract entered into with a TRICARE managed care support contractor includes requirements to ensure the provision of information regarding the pricing standard for prescription drugs.

Establishes criteria to which a carrier and a PBM must adhere under a contract or an approved plan under which the carrier has an agreement with the PBM to manage prescription drug coverage or to control the costs of such coverage.

Prohibits a PBM under such criteria from: (1) transmitting to a pharmacy owned by the PBM any personally identifiable utilization or claims data relating to an enrolled individual who has not voluntarily elected in writing or via secure electronic means to fill that particular prescription at such a pharmacy; or (2) requiring any enrolled individual to use a retail pharmacy, mail order pharmacy, specialty pharmacy, or other pharmacy entity in which the PBM has an ownership interest, or that has an ownership interest in the PBM, or give an incentive to encourage an enrollee to use the pharmacy if the incentive applies only to those pharmacies.

Requires any contract or approved plan providing for a reimbursement standard with respect to a PDP to require the carrier to: (1) update the standard at least once every seven days to reflect the market price of a drug accurately; (2) disclose to pharmacies the sources used for making any such update; (3) make advance disclosure to those pharmacies of all individual drug prices to be updated if the source for a standard is not publicly available; and (4) establish a process to appeal, investigate, and resolve disputes regarding individual drug prices less than the pharmacy acquisition price.

]]> Generic Drug Pricing Fairness Act Display Title Generic Drug Pricing Fairness Act Official Title as Introduced To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program to further transparency of payment methodologies to pharmacies, and for other purposes. Introduced in House IH Short Titles as Introduced Generic Drug Pricing Fairness Act Introduced in House 2014-12-09T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr5815ih/xml/BILLS-113hr5815ih.xml 2014-12-12 Referred to the Subcommittee on Energy and Power. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.